{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04835",
    "Peptide Name": "[Lys4, Ala13,16] brevinine-1pl (brevinine-1pl I4K,I13A,I16A analog, Synthetic AMPs, XXU; 1S=S, UCSS1a)",
    "Source": "amino acid substitution, amphibians, animal-derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "FFPKVAGVAAKVAKKAFCTISKKC",
    "Sequence Length": 24,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Antifungal",
      "candidacidal",
      "Anti-MRSA"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 6,
    "Boman Index": 0.03,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "58%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is unique and shows only very low similarity (87.5%) tobrevinine-1plK: 25%; V=F: 13%; A: 21%.Activity: S. aureus NCTC 6538 or MRSA 12,493 (MIC 8-16 uM), E.faecium NCTC 12,697 (MIC >128 uM), E. coli ATCC 8739 (MIC 16 uM), K. pneumoniae ATCC 43,816 (MIC 16 uM), P. aeruginosa ATCC CRM 9027 (MIC 32 uM), A. baumannii BAA 747 (MIC 32 uM), and C. albicans ATCC 10,231 (MIC 32 uM). MBC same or slightly higher.Structure: random coil in buffer NH4Ac and helical in 50% TFE.In vitro toxicity: horse RBC: HC50 >128 uM, less hemo.lytic.",
    "Author": "Wang J, Hu J, Pu W, Chen X, Ma C, Jiang Y, Wang T, Chen T, Shaw C, Zhou M, Wang L. 2024",
    "Reference": "Comput Struct Biotechnol J. 2024 Sep 19;23:3391-3406. doi: 10.1016/j.csbj.2024.09.006.PubMed",
    "Title": "Discovery, Development and Optimisation of a Novel Frog Antimicrobial Peptide with Combined Mode of Action Against Drug-resistant Bacteria"
  },
  "3D Structure": []
}